… In summary, this phase II trial demonstrated that glucosamine and chondroitin … severe
aromatase inhibitor-induced joint pain. The study agents were well tolerated with minimal toxicities. …

… -receptor positive breast cancer in postmenopausal women. The … with vitamins and
glucosamine/chondroitin has been … of adverse musculoskeletal symptoms such as joint pain, …

… for joint symptoms were examined in patients with breast cancer … of any controlled trials of
glucosamine specifically for the … Young et al., “Aromatase inhibitor-associated arthralgia and/…

… endocrine treatment in postmenopausal women with early-stage breast cancer. Clinical
trials … While N-acetyl-glucosamine with or without chondroitin sulfate is used to promote joint …

… In the prevention setting, the IBIS II study reported musculoskeletal … -arm studies suggest
possible benefit from glucosamine … Rastelli et al. conducted a phase 2 study that showed high …

… the end of the intervention; 2 studies, 183 women). The two studies, investigating vitamin D
and … AI cause side effects including joint and muscle pains and stiffness (aromatase inhibitors …

… This study reports that women with joint symptoms at the … with vitamins, glucosamine and
chondroitin, omega fish oils, … -arm, open-label phase II study and improved functional status [101…

… -randomized phase II trial of glucosamine and chondroitin to … label phase 2 study of duloxetine
was studied in women with … on aromatase inhibitor-associated arthralgias in women with …

… all breast cancer (53%), including invasive HR+ breast cancer … In a phase II trial, ninety
women on adjuvant anastrozole were … The discrepancy between the two studies may partially be …

… two study groups [51]. Again, this instrument did not take into account arthralgia and other
joint symptoms. … , testosterone, blue citrus, glucosamine and chondroitin. The results of these …